Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia

NCT00491296 · clinicaltrials.gov ↗

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DEVICE: SYNERGO
DEVICE: SYNERGO-intravesical chemotherapy instillation combined with hyperthermia

Sponsor

HaEmek Medical Center, Israel